SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001437749-23-007069
Filing Date
2023-03-17
Accepted
2023-03-17 16:28:55
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A vtgn20230315_s3a.htm S-3/A 405992
2 EXHIBIT 5.1 ex_489558.htm EX-5.1 7296
3 EXHIBIT 23.2 ex_489987.htm EX-23.2 2847
4 EXHIBIT 23.3 ex_489988.htm EX-23.3 2658
5 d01.jpg GRAPHIC 8223
6 vtgn.jpg GRAPHIC 10015
  Complete submission text file 0001437749-23-007069.txt   439885
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: S-3/A | Act: 33 | File No.: 333-270232 | Film No.: 23743010
SIC: 2834 Pharmaceutical Preparations